Eli Lilly Acquires Biotech Firm Dice
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
The pharmaceutical business isn't all about weight-loss drugs.
Drug-making giant Eli Lilly announced on Tuesday it agreed to buy Dice, a firm that specializes in making oral treatments for autoimmune diseases, for $2.4 billion, representing a 40% premium on Dice's shares.
Source Fool.com
